Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Which way for genetic-test regulation? Leave test interpretation to specialists

Although largely unregulated, genetic tests are increasingly used to diagnose conditions, map ancestry or predict disease risk. In this, the first of two related pieces, Arthur L. Beaudet advocates the US Food and Drug Administration banning direct-to-consumer medical tests but leaving the analysis of clinical diagnostics to specialists. In the second, Gail Javitt argues that the agency should implement a regulatory framework for all health-related tests.

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

Arthur L. Beaudet is in the Department of Molecular and Human Genetics at Baylor College of Medicine, which receives revenue from offering genetic laboratory testing.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Beaudet, A. Which way for genetic-test regulation? Leave test interpretation to specialists. Nature 466, 816–817 (2010). https://doi.org/10.1038/466816a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/466816a

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing